A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning

被引:12
|
作者
Kawahara, Daisuke [1 ]
Murakami, Yuji [1 ]
Tani, Shigeyuki [2 ]
Nagata, Yasushi [1 ,3 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Radiat Oncol, Hiroshima, Japan
[2] Hiroshima Univ, Sch Med, Hiroshima, Japan
[3] Hiroshima High Precis Radiotherapy Canc Ctr, Hiroshima, Japan
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1135期
关键词
CANCER; CT;
D O I
10.1259/bjr.20210934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To propose deep-learning (DL)-based predictive model for pathological complete response rate for resectable locally advanced esophageal squamous cell carcinoma (SCC) after neoadjuvant chemoradiotherapy (NCRT) with endoscopic images. Methods and Material: This retrospective study analyzed 98 patients with locally advanced esophagus cancer treated by preoperative chemoradiotherapy followed by surgery from 2004 to 2016. The patient data were split into two sets: 72 patients for the training of models and 26 patients for testing of the model. Patients was classified into two groups with the LC (Group I: responder and Group II: non-responder). The scanned images were converted into joint photographic experts group (JPEG) format and resized to 150 Chi 150 pixels. The input image without imaging filter (w/o filter) and with Laplacian, Sobel, and wavelet imaging filters deep-learning model to predict the pathological CR with a convolution neural network (CNN). The accuracy, sensitivity, and specificity, the area under the curve (AUC) of the receiver operating characteristic were evaluated. Results: The average of accuracy for the cross-validation was 0.64 for w/o filter, 0.69 for Laplacian filter, 0.71 for Sobel filter, and 0.81 for wavelet filter, respectively. The average of sensitivity for the cross-validation was 0.80 for w/o filter, 0.81 for Laplacian filter, 0.67 for Sobel filter, and 0.80 for wavelet filter, respectively. The average of specificity for the cross-validation was 0.37 for w/o filter, 0.55 for Laplacian filter, 0.68 for Sobel filter, and 0.81 for wavelet filter, respectively. From the ROC curve, the average AUC for the cross-validation was 0.58 for w/o filter, 0.67 for Laplacian filter, 0.73 for Sobel filter, and 0.83 for wavelet filter, respectively. Conclusions: The current study proposed the improvement the accuracy of the DL-based prediction model with the imaging filters. With the imaging filters, the accuracy was significantly improved. The model can be supported to assist clinical oncologists to have a more accurate expectations of the treatment outcome. Advances in knowledge: The accuracy of the prediction for the local control after radiotherapy can improve with the input image with the imaging filter for deep learning.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal cancer based on PET images using radiomics and machine-learning
    Murakami, Yuji
    Nagata, Yasushi
    Kawahara, Daisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [2] A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning
    Kawahara, Daisuke
    Murakami, Yuji
    Tani, Shigeyuki
    Nagata, Yasushi
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1124):
  • [3] Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
    Liu, Yunsong
    Wang, Yi
    Hu, Xinyang
    Wang, Xin
    Xue, Liyan
    Pang, Qingsong
    Zhang, Huan
    Ma, Zeliang
    Deng, Heping
    Yang, Zhaoyang
    Sun, Xujie
    Men, Yu
    Ye, Feng
    Men, Kuo
    Qin, Jianjun
    Bi, Nan
    Zhang, Jing
    Wang, Qifeng
    Hui, Zhouguang
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [4] Genomic characteristics in neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    He, Wenwu
    Leng, Xuefeng
    Wang, Kangning
    Mao, Tiaoqin
    Peng, Lin
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1105 - 1112
  • [5] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    FRONTIERS IN SURGERY, 2022, 9
  • [6] Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
    Yang, Guozhen
    Yue, Haodong
    Zhang, Xiaomin
    Zeng, Chufeng
    Tan, Linyu
    Zhang, Xu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] Neoadjuvant chemoradiotherapy followed by minimally invasive esophagectomy: is it a superior approach for locally advanced resectable esophageal squamous cell carcinoma?
    Tang, Han
    Zheng, Hao
    Tan, Lijie
    Shen, Yaxing
    Wang, Hao
    Lin, Miao
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 963 - 972
  • [8] Multimodality Deep Learning Radiomics Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
    Liu, Y.
    Wang, Y.
    Pang, Q.
    Wang, X.
    Xue, L.
    Zhang, H.
    Hu, X.
    Ma, Z.
    Deng, H.
    Yang, Z. Y.
    Men, Y.
    Ye, F.
    Men, K.
    Qin, J.
    Bi, N.
    Zhang, J.
    Wang, Q.
    Hue, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E642 - E643
  • [9] The impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus
    Lin, Jing-Wei
    Hsu, Chung-Ping
    Yeh, Hui-Ling
    Chuang, Cheng-Yen
    Lin, Chih-Hung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (01) : 18 - 24
  • [10] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12